Date Title Document
Valeant Pharmaceuticals to Hold Conference Call to Announce 2011 Financial Guidance Date 12/21/10 Title Valeant Pharmaceuticals to Hold Conference Call to Announce 2011 Financial Guidance Download PDF
Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO Date 12/20/10 Title Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO Download PDF
Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman Date 12/13/10 Title Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman Download PDF
GSK and Valeant announce receipt of U.S. FDA Complete Response letter for ezogabine Date 12/01/10 Title GSK and Valeant announce receipt of U.S. FDA Complete Response letter for ezogabine Download PDF
Valeant Pharmaceuticals to Present At Piper Jeffray 22nd Annual Health Care Conference Date 11/23/10 Title Valeant Pharmaceuticals to Present At Piper Jeffray 22nd Annual Health Care Conference Download PDF
Valeant Announces Pricing of Senior Notes Date 11/18/10 Title Valeant Announces Pricing of Senior Notes Download PDF
Valeant Launches Senior Notes Offering Date 11/18/10 Title Valeant Launches Senior Notes Offering Download PDF
Valeant Pharmaceuticals and S.A.C Capital Settle Lawsuit Date 11/04/10 Title Valeant Pharmaceuticals and S.A.C Capital Settle Lawsuit Download PDF
Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan Date 11/04/10 Title Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan Download PDF
Valeant Announces A $1.5 Billion Securities Repurchase Program Date 11/04/10 Title Valeant Announces A $1.5 Billion Securities Repurchase Program Download PDF
Valeant Pharmaceuticals to Gradient Analytics Settle Lawsuit Date 11/04/10 Title Valeant Pharmaceuticals to Gradient Analytics Settle Lawsuit Download PDF
Valeant Pharmaceuticals and Kadmon Announce Strategic   Agreement for Antiviral Therapeutics Date 11/01/10 Title Valeant Pharmaceuticals and Kadmon Announce Strategic   Agreement for Antiviral Therapeutics Download PDF
Valeant Pharmaceuticals to Acquire #2 Suncare Brand in Australia Date 10/29/10 Title Valeant Pharmaceuticals to Acquire #2 Suncare Brand in Australia Download PDF
Valeant Pharmaceuticals to Announce 2010 Third Quarter results on November 4, 2010 Date 10/25/10 Title Valeant Pharmaceuticals to Announce 2010 Third Quarter results on November 4, 2010 Download PDF
Valeant Pharmaceuticals Announces that Alexza Pharmaceuticals Has Received A Complete Response Letter For AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA Date 10/11/10 Title Valeant Pharmaceuticals Announces that Alexza Pharmaceuticals Has Received A Complete Response Letter For AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA Download PDF
Valeant and Biovail Complete Merger Date 09/28/10 Title Valeant and Biovail Complete Merger Download PDF
Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016 Date 09/27/10 Title Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016 Download PDF
Valeant and Biovail Announce Results of Special Meetings of Shareholders Date 09/27/10 Title Valeant and Biovail Announce Results of Special Meetings of Shareholders Download PDF
Valeant Announces Pricing of Senior Notes Date 09/22/10 Title Valeant Announces Pricing of Senior Notes Download PDF
Valeant and Biovail Announce Valeant's Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareholder Approval, Financing and Satisfaction of Other Closing Conditions Date 09/22/10 Title Valeant and Biovail Announce Valeant's Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareholder Approval, Financing and Satisfaction of Other Closing Conditions Download PDF
Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities Date 09/09/10 Title Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities Download PDF
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine Date 08/30/10 Title GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine Download PDF
Ezogabine, an Investigational Anti-Epileptic Drug, Receives Positive Vote from FDA Advisory Committee Date 08/11/10 Title Ezogabine, an Investigational Anti-Epileptic Drug, Receives Positive Vote from FDA Advisory Committee Download PDF
Valeant and Biovail Set Date for Shareholders Meetings Date 08/11/10 Title Valeant and Biovail Set Date for Shareholders Meetings Download PDF
Biovail Reports Second-Quarter 2010 Financial Results Date 08/05/10 Title Biovail Reports Second-Quarter 2010 Financial Results Download PDF
Biovail Declares Quarterly Dividend Date 08/05/10 Title Biovail Declares Quarterly Dividend Download PDF
Valeant Pharmaceuticals Reports 2010 Second Quarter Financial Results Date 08/02/10 Title Valeant Pharmaceuticals Reports 2010 Second Quarter Financial Results Download PDF
Biovail Announces Second-Quarter 2010 Earnings Release, Conference-Call Details Date 07/23/10 Title Biovail Announces Second-Quarter 2010 Earnings Release, Conference-Call Details Download PDF
Valeant Pharmaceuticals to Announce 2010 Second Quarter Results on August 2, 2010 Date 07/22/10 Title Valeant Pharmaceuticals to Announce 2010 Second Quarter Results on August 2, 2010 Download PDF
Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R) Date 06/23/10 Title Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R) Download PDF
Biovail and MedGenesis Announce Grant from The Michael J. Fox Foundation for the Development of GDNF Date 06/22/10 Title Biovail and MedGenesis Announce Grant from The Michael J. Fox Foundation for the Development of GDNF Download PDF
Valeant and Biovail Agree to Merge Date 06/21/10 Title Valeant and Biovail Agree to Merge Download PDF
Valeant and Biovail Agree to Merge Date 06/21/10 Title Valeant and Biovail Agree to Merge Download PDF
Valeant Pharmaceuticals to Host Investor Day Date 06/03/10 Title Valeant Pharmaceuticals to Host Investor Day Download PDF
Biovail Enters into License Agreement with Kyowa Hakko Kirin Date 06/03/10 Title Biovail Enters into License Agreement with Kyowa Hakko Kirin Download PDF
Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc. Date 05/27/10 Title Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc. Download PDF
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada Date 05/10/10 Title Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada Download PDF
Biovail Announces Increase to Quarterly Dividend Date 05/06/10 Title Biovail Announces Increase to Quarterly Dividend Download PDF
Biovail Reports First-Quarter 2010 Financial Results Date 05/06/10 Title Biovail Reports First-Quarter 2010 Financial Results Download PDF
Valeant Pharmaceuticals to Webcast 2010 Annual Meeting of Stockholders Date 05/04/10 Title Valeant Pharmaceuticals to Webcast 2010 Annual Meeting of Stockholders Download PDF
Valeant Pharmaceuticals Reports 2010 First Quarter Financial Results Date 05/03/10 Title Valeant Pharmaceuticals Reports 2010 First Quarter Financial Results Download PDF
Valeant to Acquire Vital Science Corp. in Canada Date 04/28/10 Title Valeant to Acquire Vital Science Corp. in Canada Download PDF
Valeant Pharmaceuticals to Announce 2010 First Quarter Results on May 3, 2010 Date 04/23/10 Title Valeant Pharmaceuticals to Announce 2010 First Quarter Results on May 3, 2010 Download PDF
Biovail Announces First-Quarter 2010 Earnings Release, Conference-Call Details Date 04/22/10 Title Biovail Announces First-Quarter 2010 Earnings Release, Conference-Call Details Download PDF
Valeant to Acquire Pharmaceutical Company in Brazil Date 04/21/10 Title Valeant to Acquire Pharmaceutical Company in Brazil Download PDF
Valeant Pharmaceuticals Announces Pricing of Senior Notes Date 04/07/10 Title Valeant Pharmaceuticals Announces Pricing of Senior Notes Download PDF
Valeant Plans Senior Notes Offering Date 04/06/10 Title Valeant Plans Senior Notes Offering Download PDF
Valeant Announces Increase to Securities Repurchase Program Date 03/30/10 Title Valeant Announces Increase to Securities Repurchase Program Download PDF
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression Date 03/26/10 Title Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression Download PDF
Valeant to Acquire Branded Generics/OTC Company in Brazil Date 03/19/10 Title Valeant to Acquire Branded Generics/OTC Company in Brazil Download PDF
Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date Date 03/18/10 Title Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date Download PDF
Valeant Pharmaceuticals to Present at Cowen and Company 30th Annual Health Care Conference Date 03/02/10 Title Valeant Pharmaceuticals to Present at Cowen and Company 30th Annual Health Care Conference Download PDF
Valeant Enters Collaboration With Spear Pharmaceuticals Date 03/01/10 Title Valeant Enters Collaboration With Spear Pharmaceuticals Download PDF
Biovail Declares Quarterly Dividend Date 02/25/10 Title Biovail Declares Quarterly Dividend Download PDF
Biovail Reports Fourth Quarter, Year-End 2009 Financial Results Date 02/25/10 Title Biovail Reports Fourth Quarter, Year-End 2009 Financial Results Download PDF
Valeant Pharmaceuticals Reports 2009 Fourth Quarter and Full Year Financial Results Date 02/22/10 Title Valeant Pharmaceuticals Reports 2009 Fourth Quarter and Full Year Financial Results Download PDF
Biovail Comments on Filing of Complaints Date 02/19/10 Title Biovail Comments on Filing of Complaints Download PDF
Biovail Announces Fourth-Quarter 2009 Earnings Release, Conference-Call Details Date 02/12/10 Title Biovail Announces Fourth-Quarter 2009 Earnings Release, Conference-Call Details Download PDF
Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004 Date 02/10/10 Title Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004 Download PDF
Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010 Date 02/08/10 Title Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010 Download PDF
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial Date 01/22/10 Title Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial Download PDF
Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference Date 01/06/10 Title Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference Download PDF
Biovail to Present at JPMorgan Healthcare Conference Date 01/06/10 Title Biovail to Present at JPMorgan Healthcare Conference Download PDF
Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance Date 01/05/10 Title Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance Download PDF